Radcliffe Capital Management’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

Radcliffe Capital Management’s Portfolio LUXAW Stock Details LUXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66,665	Closed	-$668K	–	1160
2022 Q3	$668K	Hold	66,665	–	–	0.02%	1021
2022 Q2	$659K	Hold	66,665	–	–	0.02%	1076
2022 Q1	$657K	Hold	66,665	–	–	0.01%	1080
2021 Q4	$653K	Hold	66,665	–	–	0.02%	942
2021 Q3	$654K	Hold	66,665	–	–	0.02%	796
2021 Q2	$659K	Hold	66,665	–	–	0.02%	818
2021 Q1	$685K	Buy	+66,665	New	+$168K	0.03%	625

Radcliffe Capital Management's LUXAW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 66,665 shares — an estimated $668K sold.

Radcliffe Capital Management first reported a position in LUXAW in Q1 2021 and held it in 7 quarters. The position peaked at $685K in Q1 2021. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

Radcliffe Capital Management reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 66,665 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $668K.
Radcliffe Capital Management first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2021 and held it in 7 quarters.
Radcliffe Capital Management's Lux Health Tech Acquisition Corp. Warrants position peaked at $685K in Q1 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.